These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 23035058

  • 1. Fingolimod and multiple sclerosis: four cautionary tales.
    Bourdette D, Gilden D.
    Neurology; 2012 Nov 06; 79(19):1942-3. PubMed ID: 23035058
    [No Abstract] [Full Text] [Related]

  • 2. Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
    Tur C, Montalban X.
    Mult Scler; 2014 Apr 06; 20(4):510-1. PubMed ID: 24468818
    [No Abstract] [Full Text] [Related]

  • 3. Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
    Ratchford JN, Costello K, Reich DS, Calabresi PA.
    Neurology; 2012 Nov 06; 79(19):2002-4. PubMed ID: 23035072
    [No Abstract] [Full Text] [Related]

  • 4. Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
    Maillart E, Louapre C, Lubetzki C, Papeix C.
    Mult Scler; 2014 Apr 06; 20(4):505-9. PubMed ID: 24367037
    [Abstract] [Full Text] [Related]

  • 5. New disease-modifying therapies and new challenges for MS.
    Yadav V, Bourdette D.
    Curr Neurol Neurosci Rep; 2012 Oct 06; 12(5):489-91. PubMed ID: 22760478
    [Abstract] [Full Text] [Related]

  • 6. Severe relapses under fingolimod treatment prescribed after natalizumab.
    Centonze D, Rossi S, Rinaldi F, Gallo P.
    Neurology; 2012 Nov 06; 79(19):2004-5. PubMed ID: 23035063
    [No Abstract] [Full Text] [Related]

  • 7. [Disease modifying drugs in multiple sclerosis and pregnancy].
    Tur C, Tintoré M, Aguilera C.
    Med Clin (Barc); 2012 Sep 22; 139(7):316-8. PubMed ID: 22743277
    [No Abstract] [Full Text] [Related]

  • 8. Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
    McNamara PH, Redmond JM, Doherty CP.
    Neurology; 2013 Jul 16; 81(3):306. PubMed ID: 23858414
    [No Abstract] [Full Text] [Related]

  • 9. Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
    Ratchford JN, Costello K, Reich DS, Calabresi PA.
    Neurology; 2013 Jul 16; 81(3):306. PubMed ID: 24024233
    [No Abstract] [Full Text] [Related]

  • 10. Multiple sclerosis: closing in on an oral treatment.
    Martin R.
    Nature; 2010 Mar 18; 464(7287):360-2. PubMed ID: 20237554
    [No Abstract] [Full Text] [Related]

  • 11. Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
    Castillo-Trivino T, Lopetegui I, Alarcón-Duque JA, López de Munain A, Olascoaga J.
    J Neurol Neurosurg Psychiatry; 2015 Aug 18; 86(8):931-2. PubMed ID: 25835036
    [No Abstract] [Full Text] [Related]

  • 12. Tumefactive multiple sclerosis lesions under fingolimod treatment.
    Visser F, Wattjes MP, Pouwels PJ, Linssen WH, van Oosten BW.
    Neurology; 2012 Nov 06; 79(19):2000-3. PubMed ID: 23035065
    [No Abstract] [Full Text] [Related]

  • 13. Multiple sclerosis reactivation postfingolimod cessation: is it IRIS?
    Alroughani R, Almulla A, Lamdhade S, Thussu A.
    BMJ Case Rep; 2014 Oct 15; 2014():. PubMed ID: 25320259
    [Abstract] [Full Text] [Related]

  • 14. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)].
    Popova NF.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011 Oct 15; 111(2 Pt 2):110-3. PubMed ID: 21916166
    [No Abstract] [Full Text] [Related]

  • 15. New drugs may improve, complicate treatment for multiple sclerosis.
    Link H, Martin R.
    Nat Med; 2010 Mar 15; 16(3):272. PubMed ID: 20208513
    [No Abstract] [Full Text] [Related]

  • 16. Re: Tumefactive multiple sclerosis lesions under fingolimod treatment.
    Kinney MO, McDonnell G.
    Neurology; 2013 Jul 23; 81(4):403. PubMed ID: 23877798
    [No Abstract] [Full Text] [Related]

  • 17. Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
    Gross CM, Baumgartner A, Rauer S, Stich O.
    Neurology; 2012 Nov 06; 79(19):2006-7. PubMed ID: 23035074
    [No Abstract] [Full Text] [Related]

  • 18. Progressive multifocal leukoencephalopathy in a patient taking the MS pill Gilenya.
    Clin Infect Dis; 2013 Oct 06; 57(8):ii. PubMed ID: 24195115
    [No Abstract] [Full Text] [Related]

  • 19. Fingolimod for multiple sclerosis.
    Pelletier D, Hafler DA.
    N Engl J Med; 2012 Jan 26; 366(4):339-47. PubMed ID: 22276823
    [No Abstract] [Full Text] [Related]

  • 20. Trial watch: Phase III promise for oral multiple sclerosis therapy.
    Nat Rev Drug Discov; 2009 Feb 26; 8(2):98. PubMed ID: 19180099
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.